Cargando…
An adjusted ELISpot-based immunoassay for evaluation of SARS-CoV-2-specific T-cell responses
Like antibody evaluation, using an effective antigen-specific T-cell immunity assessment method in coronavirus disease 2019 (COVID-19) patients, survivors and vaccinees is crucial for understanding the immune persistence, prognosis assessment, and vaccine development for COVID-19. This study evaluat...
Autores principales: | Lin, Hao, Zhang, Jie, Dong, Shaobo, Liu, Yaning, Liu, Peipei, Gao, George F., Liu, William J., Wu, Guizhen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2022 Chinese Medical Association Publishing House. Published by Elsevier BV.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9047432/ https://www.ncbi.nlm.nih.gov/pubmed/35505811 http://dx.doi.org/10.1016/j.bsheal.2022.04.005 |
Ejemplares similares
-
Comparison of SARS-CoV-2- and HCoV-Specific T Cell Response Using IFN-γ ELISpot
por: Thümmler, Laura, et al.
Publicado: (2021) -
Comparison between an in-house SARS-CoV-2 ELISpot and the T-Spot® Discovery SARS-CoV-2 for the assessment of T cell responses in prior SARS-CoV-2-infected individuals
por: Mak, Willem A., et al.
Publicado: (2022) -
SARS-CoV-2 specific T-cell immunity in COVID-19 convalescent patients and unexposed controls measured by ex vivo ELISpot assay
por: Cassaniti, Irene, et al.
Publicado: (2021) -
Optimizing SARS-CoV-2 Immunoassays for Specificity in Dengue-Co-Endemic Areas
por: Adnan, Nihad, et al.
Publicado: (2023) -
Development of an in-house SARS-CoV-2 interferon-gamma ELISpot and plate reader-free spot detection method
por: Mak, Willem A., et al.
Publicado: (2022)